Approaches to Lifestyle Management in Polycystic Ovary Syndrome

The 2014 document highlights the significance of obesity in the development and exacerbation of polycystic ovary syndrome (PCOS) symptoms and the critical role of lifestyle management in its treatment. PCOS, affecting 4-7% of women, is associated with symptoms like hyperandrogenism, menstrual irregularities, and infertility, with insulin resistance being particularly prominent in obese individuals. The document underscores that weight loss through lifestyle interventions such as diet and exercise should be the primary treatment focus, especially for obese women, as it can improve menstrual regularity, ovulation, fertility, and metabolic profiles. It also acknowledges the potential role of early weight gain and intrauterine factors in the development of PCOS and suggests that obesity worsens the PCOS phenotype. Additionally, the document considers the use of pharmacological treatments and bariatric surgery for severe cases, concluding that lifestyle interventions are essential for managing overweight and obese women with PCOS globally.